chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Progress Notes Healthcare Provider Cosign Needed Expand AllCollapse All    Healthcare Facility                                                                              Date:  3/17/2021                                                                                              Subjective Patient is a 28 y.o. male who was seen at healthcare facility today for his second  dose of the COVID 19 vaccination.    He was given the Pfizer vaccination in the left deltoid muscle.   During his 15 minute waiting period after the injection, the patient began to experience dizziness.  He denied any other symptoms.   This provider was notified of patient reaction and he was then assessed.   Monitored patient for severe reaction symptoms, including but not limited to rapid progression of symptoms.   Had back surgery 4 months ago. Since that time, he has had episodes of dizziness. 2 days after surgery, he had a syncopal episode and hit his head. He was evaluated at healthcare facility. He reports negative CT of head from that visit. He was diagnosed with concussion. He did not have a reaction with first vaccine.    ALLERGY REVIEW OF SYSTEMS:  Patient complains of dizziness   CONT negative HENT negative Eyes negative Respiratory negative Skin negative GI negative Musculo negative   Previous Reactions: N/A. No reaction to first vaccine.    Objective    Vitals Vitals:   03/17/21 0859 03/17/21 0917 BP: 128/76 116/72 Pulse: 86 80 SpO2: 100% 99%      Physical Exam Vitals reviewed.  Constitutional:      Appearance: He is ill-appearing (initially, then resolved). He is not toxic-appearing or diaphoretic.  HENT:     Head: Normocephalic and atraumatic.     Mouth/Throat:     Mouth: Mucous membranes are moist.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds. No wheezing.  Musculoskeletal:        General: Normal range of motion.     Cervical back: Normal range of motion.  Skin:    General: Skin is warm and dry.     Coloration: Skin is pale.  Neurological:     General: No focal deficit present.     Mental Status: He is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal. Behavior is cooperative.        Thought Content: Thought content normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: water Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health) Suspect this was one of his normal episodes that he has been experiencing. He is expecting a phone call with neurosurgeon this week. He was instructed to call PCP or seek emergent care if symptoms return, worsen or become worrisome. He felt back to baseline. He was able to ambulate independently.   Healthcare Provider Electronically Signed 3/17/2021 9:31 AM
On 1/16/00, child woke up with l/side facial swelling, from below lower lid to chin including left side of lips. Left clear rhinorrhea, tx with oral Atarax 1/18/00, by 1/21/00 swelling almost resolved.
pt recv vax MAR96 & approx JUL96 pt exp thinning of the hair;
Client states 4 months pregnant. Complained of lightheadedness, dizziness, weakness and nausea following injection. At one point complained of having a little trouble breathing. Client released following rest and monitoring of vital signs.
Had weakness in legs; legs cramping; increased fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Had weakness in legs), MUSCLE SPASMS (legs cramping) and FATIGUE (increased fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included TERIFLUNOMIDE (AUBAGIO) from 03-Feb-2018 to an unknown date for Multiple sclerosis.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced FATIGUE (increased fatigue). On an unknown date, the patient experienced MUSCULAR WEAKNESS (Had weakness in legs) and MUSCLE SPASMS (legs cramping). At the time of the report, MUSCULAR WEAKNESS (Had weakness in legs) and MUSCLE SPASMS (legs cramping) had not resolved and FATIGUE (increased fatigue) outcome was unknown.            No treatment medication was reported.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up contains No new information
This spontaneous report was received from a pharmacist refers to a 72 year old female patient. The patient's medical history included shingles. On 25-APR-2014, the patient was vaccinated with expired VARIVAX (Merck) lot # H006529 (dose, route and frequency were not reported) instead of ZOSTAVAX in error. No product confusion reported, just medication error, no PQC discovered. No adverse effect reported. No other information was reported. Additional information is not expected.
Breakthrough covid case. Presented to ER with c/o of bilateral ear pain, nasal congestion, sore throat, body aches, cough and exposure to covid. Hx of Moderna vaccine x 3.  Prescribed Paxlovid. DC home.
Information has been received from a physician concerning a 13 year old female who was vaccinated with a dose of Gardasil. The reporter reported that the patient claimed to have been infected by the Gardasil. The nurse who took the report reported that it was her understanding that the patient developed a case of condyloma  and physician wanted to know more information about the Gardasil vaccine to share with the patient's parents. The outcome was unknown. Additional information has been requested.
mom reports got 2nd dose of vax 3NOV02 about 10AM; had fever, fussy, cranky & had to hold pt about 4PM; t104 & 105 next Am; 5NOV sl rash;
During charting, it was found out that Tdap was given instead of the ordered DTaP. Tdap was given to 2 year old instead of DTaP. It was the patient's 4th dose. According to immunize.org, Tdap given to a child younger than 7 years as either dose 4 or 5 can be counted as valid for DTaP dose 4 or 5. Patient will come in for last dose of DTaP between age 4-5 years.
On 12/24/2021, I spent Christmas Eve with my brother and his family. It was here that I was exposed to COVID-19. On 12/26/2021, I started to feel ill. I started with nasal and ear congestion. My temperature was about 99 or 100, but I felt feverish and had mild chills. I also had a scratchy throat. Around 12/30/2021, I lost my senses of taste and smell; I finally got those back around the end of January 2022. I was tested for COVID-19 and the flu that day, but I didn't get my results until about 1/5/2022. I tested positive for COVID-19 and negative for the flu. My nasal congestion worsened afterwards. I had tinnitus prior getting COVID-19, but it intensified after I got the breakthrough case. The intensified tinnitus lasted into about February 2022. After I got COVID-19, I developed a burning sensation of the tongue accompanied by extremely dry mouth; at the time of this writing, it still occasionally comes and is an annoyance.  When I tested positive at the urgent care clinic, I was told that I qualified to receive monoclonal antibodies, but no appointment was set up for me to receive them. I just treated my symptoms with Mucinex, Tylenol, and Benadryl. I also took some Flonase and used my albuterol inhaler. I tested negative for COVID-19 on 1/11/2022.
09/14/2006 TC from client c/o itching of left upper arm in the outside area, 1st noted mid August. Itching has gradually intensified in the past 2 weeks with tingling, burning and feeling chill bumps along arm as tingling and burning extend length of arm. To MD 9/14/06 given prednisone 50 mg QD x 5 days. Blood drawn for testing client to return to MD 9/15/06.
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 68-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included kidney transplant. On 11th March 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). On 11th March 2019, less than a day after receiving SHINGRIX, the patient experienced shivering, fever and exhaustion. On an unknown date, the outcome of the shivering was recovered/resolved and the outcome of the fever was not recovered/not resolved and the outcome of the exhaustion was unknown. It was unknown if the reporter considered the shivering, fever and exhaustion to be related to SHINGRIX. Additional details were provided as follows: The patient reported that on evening of vaccination, she felt exhausted and had intense shivering for about 30 to 45 minutes and experienced fever of 99 degrees Fahrenheit. The caller reported fever was persisting on the day of reporting. The reporter gave consent to follow up.
Day of injection after I left the vaccination site I started to have a really bad headache and then sore arm (left arm where the injection was). Then about 7 hours after the injection I started to have a really bad stomach ache and cramps with nausea. This last all night long into the next day where it slowly went away. I was incredibly fatigued and the headache would not break. Then on the 3rd day Thursday January 7 I was feeling okay but not 100% myself. Then Friday January 08 I woke up and knew something was incredibly wrong because my stomach hurt way worse then before, i was so lethargic that I was falling asleep at my desk at work, I was shaking  uncontrollably, blurred vision, diarrhea with blood in stool and one close episode of fainting.  So at the point I ended up in the ER missing the rest of my work day. My symptoms didn't get better until the following Monday
Site: Bruising at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Error: Wrong Route (SC, IM, etc.)-, Additional Details: Patient noted itch on 10.15.21 to left arm. On the 17th the entire left arm was numb. Today noted itch and bruising band around left arm. Bruise looked to be about 1 and 1/2 to 2 inches tall. Rash was around lower left bicep. Patient state dthe administrater gave the shot in arm and not in deltoid. I questioned about how the shot was administered. He response was I dont remember every shot i Have given.
Significant swelling to (R) thigh after 4th HIB. Started approximately 12 hours post injection. No fever no pain no redness at injection site.
Information has been received from a consumer concerning her daughter, a 17 year old female with a history of drug hypersensitivity to amoxicillin and sulfates, who on approximately 01-AUG-2007 was intramuscularly vaccinated with her second dose of Gardasil.  On 15-AUG-2007 the patient experienced hives, numbness in arms and legs, tingling in arms and legs and headaches.  The patient sought unspecified medical treatment in the ER where an MRI was performed.  Therapy was reported as discontinued as of "October 2007".  The patient's hives, numbness and tingling in arms and legs, and headaches have not improved.  Additional information has been requested.
Approximately 10 minutes after vaccine patient had c/o flushing for approximately 15 minutes.
Fever, peaking at 101.5 F, starting at approx 2 am 4/12 lasting until approx 4 pm. Severe nausea from 2 am 4/12, lessening but continuing through following day (the day this report is written). Mild vomiting and diarrhea at 7 am 4/12 not continuing. Severe jaw pain starting 48 hours after vaccination (approx 12 pm 4/13) on right side of jaw, constant and intense, not limiting ability to move but preventing focus on tasks. Mild pain in some lymph nodes, mild headache, moderate fatigue not inconsistent with having been recently ill. All symptoms dealt with by patient without seeking medical intervention. OTC anti-nausea was taken without relief.
Swelling and subdermal bleeding from injection site to elbow.  Patient presented on 10/21/20 with bruising above elbow due to the bleeding.
Mild fever, and "droppsies" per patient. Then 11/7/2012 patient called with severe itching at the site of both vaccines, mild fever, and "not able to get her thoughts together."
COVID Breakthrough case Symptoms began: 08/06/2021 Lab confirmed: 08/06/2021
Sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Oct-2021 and was forwarded to Moderna on 30-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-369213 (Patient Link).
Child presented on 7/30 (age 27 d) with vomiting -> GERD, FPIES and new onset painful lump right thigh. Ultrasound -> ?hematoma. Follow up 8/5 -> marked induration, pain -> ER (abscess drained MRSA).
A nurse reported that 10 minutes post vax, the pt developed welts and a rash over his body. He was treated with Zyrtec 1/2 tsp/day and Benadryl 3/4 tsp to 1 tsp as needed for 3 days. The pt recovered. Additional information received from the reported indicated that a the time of vax, the pt was taking Cezil. The pt remained recovered.
Gradually worsening eczema symptoms on body and hands starting a few weeks after vaccine, prescribed methotrexate, currently no improvement
This spontaneous case reported by a nurse, describes the occurrence of general malaise, somnolence (slept the rest of the day) and nausea (nauseated) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced general malaise, somnolence (slept the rest of the day) and nausea (nauseated). At the time of the report, general malaise, somnolence (slept the rest of the day) and nausea (nauseated) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medications. Patient rested for the day and felt better.
Fatigue, new onset persistent cough, bilateral leg swelling, growths on hands that looked like warts, vertigo, right sided facial droop, difficulty walking (was independent, now needs a walker to ambulate), balance issues, new diagnosis of avascular osteonecrosis in right hip, brain fog.
This spontaneous report was received from a registered nurse and refers to a 18 month old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient might have been vaccinated with a dose of GARDASIL 9 lot # M024261, expiration date 30-JUL-2017 (dose, route of administration were not reported), for prophylaxis. The concomitant medication included hepatitis A vaccine (manufacturer unknown) administered on an unknown date. The nurse reported that the patient's medical record indicated that a dose of Hepatitis A vaccine (manufacturer unknown) was administered, but the recorded lot number and expiration date "seemed to correspond to GARDASIL 9". No adverse reactions were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
This spontaneous report was received from a 62 year old female patient, who was also a pharmacist and reported on herself. The patient had no pertinent medical history and no drug reactions or allergies. Concomitant therapies included metoprolol and SYNTHROID. On an unknown date in November 2014, the patient was vaccinated with ZOSTAVAX (dose, route, lot # and expiration date were not reported). On an unknown date in 2015 (reported as either January or February), the patient began to experience a tingling sensation on her left side, near her waist. On an unknown date in 2015, either in February or March (reported as a month later), she began to experience tingling in her left eye every once in a while. The patient sought medical attention by calling the physician. There was no treatment given for the adverse events. No laboratory tests were performed. The outcome of tingling sensation and pinching in the eye was reported as not recovered. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
11 days after the injection a large red patch appeared suddenly  around injection site after lifting something heavy. It is hot to the touch, swollen and slightly itchy. The muscle feels tender and sore. Patch is about 2.5 inches in diameter.
Menstrual cycle stoped for 2 months returning with a massive heavy flow.  My cycles usually run 3 to 3 1/2 day and now I have a full 7 day cycle with extreme heavy flow! I also experience Brain fog  along with muscles in fingers, thumb and arm twich intermittently.
This spontaneous report as received from a nurse refers to an unknown number of patients of an unknown age and gender. Medical history was not reported. On an unknown date about 50 doses of VARIVAX (Merck) (route, dosage, lot# and expiration date were not reported), were administered to unspecified patients since VARIVAX (Merck) underwent a temperature excursion. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
The patient (demographics unknown) along with some other nurses, whose medical history and concomitant vaccinations were not reported, had received a dose of FLLUZONE ID vaccine (lot number: UT4474AA, dose number and anatomical site of administration not reported) on an unspecified date. It was reported that on an unspecified date, the patient and other nurses experienced bad itching and induration. Laboratory details and corrective treatment were not reported. As of 08 OCTOBER 2012, the outcome of the events was not reported. Documents held by sender: none.
Significant hair loss/hair started to fall out in large amounts/hair was so thin now and she could see her scalp; low grade fever; body aches; This is a spontaneous report from a contactable consumer (patient). A 42-years-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6207, Expiration date was not reported), via an unspecified route of administration on 23Mar2021 as dose 1, single for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing and COVID-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. There were no concomitant medications in two weeks. Patient had no other vaccine in four weeks. Patient had not been tested for COVID-19, post vaccination. On 23Mar2021, after patient got the vaccine that night, patient just had a low grade fever and body aches. This continued for about 3-4 days. Patient took Tylenol and it went away. On 29Mar2021, by day 7, patient hair started to fall out in large amounts/significant hair loss. Up until today large amount continues to fall out. Patient hair was so thin now and she could see her scalp. This was the first dose, patient stated that she could only imagine after she get the second one. Therapeutic measure were taken for low grade fever and body aches and treatment included Tylenol and received no treatment for significant hair loss/hair started to fall out in large amounts/hair was so thin now and she could see her scalp. The outcome of significant hair loss/hair started to fall out in large amounts/hair was so thin now and she could see her scalp was not recovered and recovered for low grade fever and body aches on Mar2021.  No follow up attempts are possible. No further information is expected.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/27/2023 Discharge Date: Mar 3, 2023  PRESENTING PROBLEM: Subdural hematoma  Hypoxia  Fall from standing, initial encounter  COVID-19    HOSPITAL COURSE: Patient is a 103 y.o. female with a past medical history of atrial fibrillation on apixaban, hyperlipidemia, choledocholithiasis status post ERCP in 2019, presenting after a fall at her independent living facility.  The patient suffered an unwitnessed fall at approximately 6:00 p.m. on 02/27 was brought to the emergency department.  The patient is extremely hard of hearing and is unable to provide history.  In the emergency department the patient was afebrile but tachycardic to the 130s.  EKG showed atrial fibrillation with RVR. She was started on metoprolol with good response in heart rates.  The patient was found to be COVID positive.  Chest x-ray showed bilateral infiltrates consistent with edema.  BNP was elevated to 4000, though stable from prior.  Troponins mildly elevated but flat.  The patient did become hypoxic and required 2 L nasal cannula.  Labs were significant for glucose of 121, bili of 1.2, AST of 51, hemoglobin of 12, white blood cell count of 629, platelets 245.  CT head was obtained that showed a subdural hematoma as well as small amount of subarachnoid hemorrhage.  Neurosurgery was contacted, as well as the patient's son/durable power of attorney, and per report from the emergency department the emergency department physician was also able to converse with the patient.  It was noted that the patient and her son did not want to pursue any surgical intervention under any circumstances.  Given the desire for no surgical intervention emergency department did discuss with Neurosurgery and felt that the patient did not require transfer to Hospital. The patient was subsequently admitted to the medicine service for further care.    Repeat CT head was stable with no further bleeding. Eliquis was stopped. Her mentation improved, though at times quite difficult to communicate with because of how hard of hearing she is, even with hearing aids.    She required oxygen from both fluid overload from CHF and COVID. She was started on steroids for COVID. She was diuresed with Lasix and improvement in oxygenation. Oxygen requirements were weaned. She did require some oxygen and pulmonary rehab was consulted who recommended 1L at rest and 3L with activity. Given her clinical stability she was discharged back to her assisted living facility on 3/3/23.  Patient passed away on 3/3/23 at Assisted Living Facility